CD68 and neoplasm: As shown in Fig. 2b, c, GCB DLBCLs were also characterized by the expression of the KI67 proliferation marker, the tumor-associated macrophage (TAM) marker CD68, and cytotoxic and immune escape markers (GRB, PD-L1, and PD-L2).